Safety of topical dermatologic medications in pregnancy

Viral M. Patel, Robert A. Schwartz, W. Clark Lambert

Research output: Contribution to journalArticlepeer-review

Abstract

Dermatologic drugs should be employed with caution in women of childbearing age who are pregnant or considering pregnancy. Topical drugs have little systemic absorption. Therefore, they are deemed safer than oral or parenteral agents and less likely to harm the fetus. However, their safety profile must be assessed cautiously, as there is limited available data. In this article, we aggregate human and animal studies and provide recommendations on using topical dermatologic medications in pregnancy.

Original languageEnglish (US)
Pages (from-to)830-834
Number of pages5
JournalJournal of Drugs in Dermatology
Volume15
Issue number7
StatePublished - Jul 2016

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint

Dive into the research topics of 'Safety of topical dermatologic medications in pregnancy'. Together they form a unique fingerprint.

Cite this